Skip to content

A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02843594
Enrollment
500
Registered
2016-07-26
Start date
2016-08-31
Completion date
2018-09-30
Last updated
2016-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

The purpose of this research study is to evaluate the clinical outcomes of different cataract surgical techniques for lens fragmentation in subjects undergoing routine cataract surgery.

Interventions

PROCEDURELEEP intervention

Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation

PROCEDUREStandard Phaco Control

Sponsors

Iantech, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Able to understand study requirements, willing to follow study instructions and willing to return for required study follow-up visits as confirmed by provision of written informed consent. 2. Subjects with a visually significant cataract scheduled to undergo cataract surgery 3. Subjects \> 18 years of age 4. BCVA at baseline not better than 20/40 5. Grade 1+ cataracts

Exclusion criteria

1. Subjects not able to complete the informed consent form 2. Subjects \< 18 years of age 3. Polar cataracts 4. Zonular instability

Design outcomes

Primary

MeasureTime frameDescription
Cumulative Dispersed Phaco energyIntraoperativeTotal phaco power and energy used as recorded by the phaco machine

Secondary

MeasureTime frameDescription
Endothelial cell loss1 monthChange from baseline endothelial cell density as measured by specular microscopy

Countries

Panama

Contacts

Primary ContactJennifer Gaines
admin@iantechmed.com+1 (415) 295-4770

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026